Patent · US Active

Pyrrolidine derivatives as NK-3 receptor antagonists

US8293770B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Caterina Bissantz · Rixheim, FR
Philippe Jablonski · Steinbrunn-le-Haut, FR
Henner Knust · Rheinfelden (Baden), DE
Matthias Nettekoven · Weil am Rhein, DE
Angelique Patiny-Adam · Kembs, FR
Hasane Ratni · Habsheim, FR
Claus Riemer · Glückstadt, DE

Key dates

Filing date	Oct 2, 2009
Grant date	Oct 23, 2012
Priority date	—
Expiry date	Aug 1, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formula Iwherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.